Connect with us
A BioSim study highlights biosimilars’ crucial role in reducing Spain’s healthcare spending, projecting €22.27 billion in savings from 2024–2030. Despite rising biologic drug costs, biosimilars ensure...
The service, also known as AlphaID At Home, is Grifols' first FDA-cleared service for direct-to-consumer use. It will be available beginning in the second quarter of...